openPR Logo
Press release

Polymyalgia Rheumatica Treatment Market Size, Share, Growth, Analysis, Report and Forecast 2024-2032

01-12-2024 06:25 AM CET | Health & Medicine

Press release from: Expert Market Research

Polymyalgia Rheumatica Treatment Market

Polymyalgia Rheumatica Treatment Market

Polymyalgia Rheumatica Treatment Market Outlook

According to the report by Expert Market Research (EMR), the global polymyalgia rheumatica treatment market size is projected to grow at a CAGR of 4.7% between 2024 and 2032. Aided by the increasing focus on personalised medicine, the market is expected to grow significantly by 2032.

Polymyalgia rheumatica is an inflammatory disorder typically affecting adults over the age of 50. It is characterised by muscle pain and stiffness, particularly in the shoulders, neck, and hips. The precise cause of PMR is unknown, but it is believed to be related to autoimmune reactions and genetic factors.

The global polymyalgia rheumatica treatment market demand is primarily driven by the increasing prevalence of this condition, particularly among the aging population. The rise in the elderly population, who are more susceptible to such inflammatory diseases, is a key factor contributing to the market growth. Furthermore, advancements in medical research and diagnostics are enabling better identification and treatment of PMR, further fuelling market expansion.

Get a Free Sample Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market/requestsample

The primary treatment for polymyalgia rheumatica involves corticosteroids, which are effective in reducing inflammation and pain. The market for PMR treatment includes a range of corticosteroids, with prednisone being the most commonly prescribed medication. However, long-term use of corticosteroids is associated with potential side effects, leading to the demand for safer and more effective treatment options.

Biologic therapies are account for a significant portion of the polymyalgia rheumatica treatment market share. These therapies, which include tumour necrosis factor (TNF) inhibitors and interleukin-6 (IL-6) receptor blockers, offer targeted treatment and are often used in patients who do not respond adequately to corticosteroids. The development and approval of new biologic agents are expected to provide impetus to the market growth.

One of the key polymyalgia rheumatica treatment market trends is the growing focus on personalised medicine. Understanding the genetic and environmental factors contributing to PMR is leading to more tailored treatment approaches, improving patient outcomes and treatment efficacy.

Read Full Report with Table of Contents@
https://www.expertmarketresearch.com/reports/polymyalgia-rheumatica-treatment-market

The market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America and Europe are leading markets due to the high prevalence of PMR, well-established healthcare systems, and the presence of key pharmaceutical companies engaged in PMR research. The Asia Pacific region is also witnessing growth, driven by increasing awareness and improving healthcare infrastructure.

Polymyalgia Rheumatica Treatment Market Segmentation

The market can be divided based on diagnostic method, drug class, route of administration, end use, and region.

Market Breakup by Diagnostic Method

Blood Tests
Imaging Tests

Market Breakup by Drug Class

Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Nonsteroidal Anti-Inflammatory Drugs
Others

Market Breakup by Route of Administration

Oral
Parenteral

Market Breakup by End Use

Hospitals
Homecare
Speciality Clinics
Others

Market Breakup by Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the global polymyalgia rheumatica treatment market. Some of the major players explored in the report by Expert Market Research are as follows:

Sanofi SA
Apotex Corporation
GlaxoSmithKline plc
AbbVie Inc.
Horizon Therapeutics plc
Others

Read More Reports

GNSS Simulators Market: https://www.expertmarketresearch.com/reports/gncc-simulators-market

Electric Scooter and Motorcycle Market: https://www.expertmarketresearch.com/reports/electric-scooter-and-motorcycle-market

Electric Mop Market: https://www.expertmarketresearch.com/reports/electric-mop-market

Electric Drives Market: https://www.expertmarketresearch.com/reports/electric-drives-market

Cristobalite Market: https://www.expertmarketresearch.com/reports/cristobalite-market

Bio-Based Platform Chemicals Market: https://www.expertmarketresearch.com/reports/bio-based-platform-chemicals-market

Media Contact

Company Name: Claight Corporation
Contact Person: Christopher, Business Consultant
Email: sales@expertmarketresearch.com
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analysis provides the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.

Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polymyalgia Rheumatica Treatment Market Size, Share, Growth, Analysis, Report and Forecast 2024-2032 here

News-ID: 3350086 • Views:

More Releases from Expert Market Research

Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
Bed and Bath Linen Market Trends, Growth & Forecast 2025-2034
The global bed and bath linen market is witnessing strong growth due to increasing consumer focus on home décor, comfort, and luxury. Rising disposable incomes, urbanization, and the booming hospitality sector are further boosting demand for premium-quality bed sheets, pillowcases, towels, and bathrobes. Technological innovations in fabrics, such as antimicrobial, wrinkle-resistant, and sustainable textiles, are shaping consumer preferences. In addition, the expansion of online distribution channels has made luxury and
Global Fruit Juice Market Size, Report and Forecast 2025-2034
Global Fruit Juice Market Size, Report and Forecast 2025-2034
The latest report from Expert Market Research titled, "Global Fruit Juice Market Size, Report and Forecast 2025-2034," offers a comprehensive analysis of the global fruit juice market, examining it across various segments such as types, flavours, distribution channels, and key regions. The report identifies and tracks the latest trends shaping the industry and evaluates their impact on the overall market dynamics. It also provides a thorough assessment of the market, covering
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
Global Fluorspar Market Forecast 2025-2034: Growth, Trends, and Key Insights
According to the latest report by Expert Market Research (EMR), the global Fluorspar Market Size is projected to grow at a CAGR of 5.60% between 2025 and 2034. The market is expected to experience significant growth by 2034, driven by the increasing demand for fluorspar across industries such as manufacturing, chemicals, and metallurgy. Fluorspar, also known as fluorite, is a key industrial mineral composed of calcium fluoride (CaF2). It is crucial
Why will smart pulse oximeters market hit $3.50Bn by 2034?
Why will smart pulse oximeters market hit $3.50Bn by 2034?
smart pulse oximeters market Overview The smart pulse oximeters market has become a pivotal part of modern healthcare infrastructure, especially in the wake of increasing cardiovascular and respiratory ailments. These technologically enhanced devices measure blood oxygen saturation and pulse rate, often offering wireless connectivity to mobile apps for better health tracking. Their growing application in hospitals, ambulatory settings, and home healthcare environments reflects the market's evolving dynamics. Key drivers include the

All 5 Releases


More Releases for Polymyalgia

Polymyalgia Rheumatica Market Trends, Treatment Advances, and Growth Opportuniti …
Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder primarily affecting adults over 50, characterized by muscle pain and stiffness, particularly in the shoulders and hips. The disease significantly impacts quality of life and daily functioning, making timely diagnosis and effective treatment essential. With an aging global population and growing awareness of inflammatory conditions, the Polymyalgia Rheumatica market is poised for substantial growth, driven by advancements in therapeutics, diagnostic capabilities, and
Polymyalgia Rheumatica Market to Hit $322.49 Mn by 2034
The global healthcare industry is increasingly focused on addressing chronic inflammatory conditions, among which polymyalgia rheumatica (PMR) holds a distinct place. Primarily affecting individuals over the age of 50, PMR is characterized by pain and stiffness in the shoulders and hips, often linked to systemic inflammation. According to Expert Market Research, the global polymyalgia rheumatica treatment market attained a value of USD 203.73 million in 2024 and is expected to
Polymyalgia Rheumatica Treatment Market would grow upto USD 513.47 million by 20 …
The global polymyalgia rheumatica treatment market is expected to witness significant growth during the forecast period. This disorder mainly occurs in ageing people aged above 60 years. It is more dominant in females than males, with a ratio of 2:1. Polymyalgia rheumatica is an autoimmune disease with no identified cause, however its been suggested that there is a link between genetic and environmental factors leading to the spread of this
Polymyalgia Rheumatica Market Expected to Reach US$ 9,623.4 Million by 2033 | IM …
The newly published report by IMARC Group, titled "Polymyalgia Rheumatica Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive analysis of the polymyalgia rheumatica market. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends. In addition, the report offers competitor analysis, regional analysis, and
Polymyalgia Rheumatica Market - Empowering Comfort, Embracing Movement: Polymyal …
Newark, New Castle, USA: The "Polymyalgia Rheumatica Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Polymyalgia Rheumatica Market: https://www.growthplusreports.com/report/polymyalgia-rheumatica-market/8813 This latest report researches the industry structure, sales, revenue,
Polymyalgia Rheumatica Market Report, History and Forecast 2021-2031
Newark, New Castle, USA - Growth Plus Reports has published a new report on Polymyalgia Rheumatica Market, which includes a detailed analysis based on competitors and important market segments (2023-2031). The Global Polymyalgia Rheumatica provides a thorough analysis of many segments such as opportunities, market size, developments, innovation, sales, and overall growth of leading players. The research is based on primary and secondary statistical data, and it includes both intuitive